L&G PHARMA BREAKTHROUGH ETF |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.15 USD | +0.76% |
|
+0.88% | -13.95% |
| 2018 | ETFS Pharma Breakthrough GO UCITS ETF has Changed its Name to L&G Pharma Breakthrough UCITS ETF | CI |
Description
| IE00BF0H7608 | |
|---|---|
| Total Expense Ratio | 0.49% |
| Asset Class | Actions |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | Solactive Pharma Breakthrough Value NTR Index - USD |
Features and characteristics
| Dividend Policy | Capitalisation |
|---|---|
| Replication Method | Physique |
| Jurisdiction | |
| Replication Model | |
| Date of creation |
22/01/2018
|
| Geographical Focus |
AuM evolution ( 30/05/2024 )
| AuM (EUR) | 17 M€ |
|---|---|
| AuM 1M | 17 M€ |
| AuM 3 months | 21 M€ |
| AuM 6 months | 28 M€ |
| AuM 12 months | 56 M€ |
- Stock Market
- ETF
- BIOT ETF
- News L&G Pharma Breakthrough ETF
- Other languages
